ABSTRACT AIMS -This study investigates the prevalence of use of doping agents and symptoms of eating disorders among patients in drug addiction treatment. The aim is also to look for characteristics of the groups reporting the use of doping agents or symptoms of eating disorders. DESIGN -A survey including questions on exercise, the use of doping agents and Eating Disorder Inventory-2 was administered in a Norwegian drug addiction facility. The study included 109 patients in residential drug treatment, 30 females and 79 males (ranging from 17 to 50 years old). RESULTSSymptoms of eating disorders were reported by 33 percent of the females and 7.6 percent of the males. Previous use of doping agents (anabolic-androgenic steroids in particular) was reported by 40.5 percent of the men and 20 percent of the women. The results are discussed in light of the theory on emotion regulation, gender and cultural expectations, drug treatment as a liminal phase and similarities to drug addiction. CONCLUSIONS -The symptoms of eating disorders and the use of doping agents are prevalent in this sample of male and female drug addicts in treatment. Drug treatment facilities should be aware of this and take the appropriate actions regarding attention, screening and treatment.
Introduction
Research from the last three decades has revealed a co-prevalence between substance disorders and eating disorders (CaleroElvira et al., 2009; Courbasson, McLaughlin, Letchumanan & Wong, 2010; Harrop & Marlatt, 2010; Holderness, Brooks-Gunn & Warren, 1994; Krahn, 1993; Nøkleby, 2012) . In short, these reviews have found that among women a correlation exists between bulimic behaviour/bulimia/nonrestricted type of anorexia (a type of anorexia that includes binge eating or purging) and an increased level of substance use/ abuse/dependence. It is suggested that there is a common aetiology between eating disorders and substance disorders: personality traits such as reward sensitisation (Calero-Elvira et al., 2009) , impulsivity ( Thompson-Brenner et al., 2008) , high interpersonal sensitivity (Carbaugh & Sias, 2010) , neuroticism (high levels of negative affect such as depression and anxiety, low self-esteem) (Baker, Mazzero & Kendler, 2007) , insufficient regulations of emotions (Root et al., 2010) and insecure attachment (Miljkovitch, Pierrehumbert, Karmaniola, Bader & Halfon, 2005) .
There are significant differences between men and women in terms of eating disorders. Males constitute only approximately ten percent of the total group with anorexia nervosa and bulimia nervosa (American Psychiatric Association, 2000) ; the percentages are higher among individuals with pathological overeating and "eating disorders not otherwise specified" (EDNOS) (Ousley, Cordero & White, 2008; Striegel-Moore et al., 2009 ). This affects the gender composition in the sample with both eating and drug disorders, although men make up about two thirds of the drug addiction population (Amundsen, 2010; SAMHSA, 2011) . However, the affected males seem increasingly more visible, partly because the development of diagnosis and assessment instruments has occurred in a less feminine way (for instance, the proposed changes in DSM-5 criteria, www.dsm5.org).
Research has also shown correlations between substance use/abuse and the use of performance-enhancing drugs or doping agents, such as anabolic-androgenic steroids. Outside elite sports, doping agents are frequently more often associated with weight lifting (Graham, Davies, Grace, Kicman & Baker, 2008; Santos, da Rocha & da Silva, 2011) , illicit drug use (Hakansson, Mickelsson, Wallin & Berglund, 2012; Denham, 2009; Dodge & Hoagland, 2011; Ip, Barnett, Tenerowicz & Perry, 2011) , conduct disorder and criminal behaviour (Pope, Kanayama & Hudson, 2012; Skårberg, Nyberg & Engström, 2010) and body image problems and eating disorders (Morgan, 2008; Pope et al., 2012) . Outside the sports arenas doping agents are used significantly more often by men than by women (Lenehan, 2003) .
Previous studies have shown that drug treatment may lead to overweight (Cowan & Devine, 2008; Hodgkins, Jacobs & Gold, 2003) and that diagnostic eating disorders are often insufficiently dealt with in drug treatment (Bonfa et al., 2008) 
Methods

Sample
The participants were male and female drug addicts in treatment. Of the 129 patients available for the study, 109 partici- (Table 1) . The women were slightly younger than the men. The main substances reported to be used prior to referral were amphetamines, heroine/opiates, cannabis, alcohol and benzodiazepines/sedatives.
Setting
All participants were patients in a Norwegian non-governmental institution offering long-term residential treatment. The average time spent in treatment at the time of the study period was eight months. Possessing or using doping agents was liable to lead to expulsion from treatment. The acquiring -not the use -of doping agents is illegal in Norway, if not medically prescribed. The legal status of using is now under debate.
Instrument
The survey included questions on exercise and the use of doping agents, as well as the standardised instrument Eating Disorder Inventory-2 (EDI-2, Garner, 1991 These questions on exercise and the use of doping agents were drawn from a Norwegian prevalence study on the use of doping agents among military recruits (Barland & Tangen, 2009 ). The survey also included such background questions as sex, age group and most used substance prior to treatment.
EDI-2 measures symptoms of eating disorders. In previous studies, the has been shown to discriminate between samples of eating disorder patients and non-clinical individuals (Garner, 1991; Nevonen, Clinton & Norring, 2006; van Strien & Ouwens, 2003) . It also appears to be well suited for screening for eating disorder symptoms in the general population (Clausen, Rokkedal & Rosenvinge, 2009 ).
The test-retest reliability was found to be high (Thiel & Paul, 2006) . In Norway, Jan Rosenvinge (1998) has translated the EDI-2, which has primarily been used clinically; a Norwegian validation study has not yet been carried out. In Sweden (Nevonen et al., 2006) and Denmark (Clausen et al., 2009 ), validation studies have been conducted and normative data obtained.
In view of possible cultural variations between different countries, a thorough cross-cultural adaption of the instrument is recommended (Gjersing, Caplehorn & Clausen, 2010) . However, for this introductory study on the area in Norway, other Nordic studies were considered offering acceptable comparison data. The fact that EDI-2 provides particularly useful data on the sample's psychological profile has (Bruch, 1973 , 1982 , in Garner, 1991 . Bulimia assesses binge eating and is the defining characteristic of bulimia nervosa. Body Dissatisfaction measures overall unhappiness with shape and size of specific parts of the body.
The eight psychological subscales measure attributes relevant to eating disorders (Garner, 1991) . Insecurity assesses a belief that social relationships are generally disappointing, unrewarding and insecure (Garner, 1991) .
The scoring system in EDI-2 reflects the idea that responses in the non-symptomatic direction (scoring less than 4 on a 6-point scale, ranging from 1 to 6) should not be counted. Subscale scores were computed, allowing only one subscale item to be omitted, in accordance with the EDI manual (Garner, 1991) .
The EDI-2 does not operate with fixed cut-off values to identify individuals with eating disorders or eating disorder symptoms (Garner, 1991) . Still, Garner has suggested using a score on Drive for Thinness as a cut-off in the screening process, as this subscale touches the core psychopathology of both anorexia and bulimia (Bruch, 1973 , 1982 , in Garner 1991 . The proposed cut-off is 14, although Garner advises that the level be adjusted according to purpose.
Other cut-off values may be derived from the symptom index that comprises all three symptom subscales, or just Drive for Thinness and Bulimia (see Nøkleby, 2013) .
For boys/men with the typical diagnostic eating disorders (anorexia and bulimia), EDI-2 has demonstrated its usefulness and validity (Spillane, Boerner, Anderson & Smith, 2004) . In a study that compares matched male and female eating disorder As we had no Norwegian norm data, a Swedish study was used for comparison (Nevonen et al., 2006) . In the Swedish study, three samples were assessed: eating disorder patients, psychiatric outpatients and a non-clinical control sample. In the present study, we used data from the sample of eating disorder patients. The eating disorder patients were women between 18
and 24 years of age (N=978). They were diagnosed according to DSM-IV with anorexia nervosa (18 percent), bulimia nervosa (44 percent) and eating disorder not otherwise specified (38 percent) (Nevonen et al., 2006) . The patients had been recruited from 15 eating disorder specialist centres in Sweden (Nevonen et al., 2006) .
These Swedish data were compared to our data through unpaired t-tests, using mean scores and standard deviations (SD).
Internal consistency of EDI-2
Cronbach's Alpha was used to test the internal consistency of the EDI-2 subscales applied on this sample (Table 3) .
Two of the symptom subscales (Drive for
Thinness, Body Dissatisfaction) as well as 
Results
Symptoms of eating disorders
The 11 EDI-2 subscale scores for the total sample, and for women and men separately, are presented in Table 4 .
Comparing men and women, we found that women had on average higher scores on all subscales, except for Maturity Fears, where men had the highest scores. Significant gender differences were found in We compared this group to a sample of eating disorder patients from a Swedish study (Nevonen et al., 2006 Testing for preferred drug prior to treatment, this subgroup used amphetamine significantly more often than the rest of the sample, OR 3.5 (p<0.04).
In terms of motivation for exercise, the eating disorder symptoms group answered "get in shape", "get a beautiful body", "feel well" and "lose a few kilos" significantly more often than those scoring below 12 on Drive for Thinness (Table 6 ).
The eating disorder symptoms group reported "get bigger muscles" significantly less as their motivation. Other motives for exercise were equally distributed between those scoring above and below 12.
Use of doping agents
According to the results, 40.5 percent (32) of the men and 20.0 percent (6) of the women reported having used doping agents.
The predominant preparations used were anabolic-androgenic steroids (used by 78.9 percent) and testosterone (used by 59.5 percent). Furthermore, 23.7 percent of this group (8.3 percent of the total sample) had been using during the last year, while the rest prior to the last year.
The motivation for using various doping agents was related primarily to the concrete, physical appearance (e.g. "get the body I want" and "get big muscles") ( Figure 1 ). It was less related directly to this body's effect on others (e.g. "be able to defend myself").
However, looking at their motivation for physical exercise in general (Table 6 ), the group who had been using doping agents was significantly more prone to answer "defend myself or my dearest ones" than the rest of the sample who had not used doping agents. The non-users reported "have something to do" significantly more often than users as a motive for exercise.
In addition, users had significantly more often been engaged in regular sporting activities in their childhood and youth than the non-users, OR 4.1 (p=0.03).
No differences occurred between the users and the non-users regarding which 
Discussion
Regulating emotions
The current study identified a subgroup of the drug addiction sample reporting symptoms of eating disorders. The group showed high scores in the pursuit of thinness. Compared with the rest of the drug addiction sample, this subgroup was characterised by poor self-esteem, difficulties with identifying and expressing their feelings, denial of bodily needs and inadequate impulse control (as measured by EDI-2). These find- 
Gender and cultural expectations
Eating disorder symptoms, particularly the pursuit of thinness, are far more widespread among women than among men in this study. This result is in accordance with previous research (Hudson, Hiripi, Pope & Kessler, 2007; Keel, 2010) , which may be at least partly related to cultural expectations (Dworkin & Wachs, 2009 ).
With changing cultures, the proportion of boys and men with eating disorders may be rising. However, an inventory such as EDI-2 has a rather feminine bias with a focus on the female body, as do many eating disorder inventories. Thus, boys' and men's eating disorders may be overlooked.
Also identified is a substantial subgroup using doping agents, a group in which This motivation and emphasis on bodily appearance can be seen in relation to substance treatment as a liminal phase (Turner, 1967; 1969) . The liminal phase is the in-between phase in a transition process (a rite de passage) in which the individual no longer inhabits its previous role and
has not yet reached its new role (van Gennep, 1960) . Residential drug treatment resembles the liminal phase in several ways.
The patient is in an in-between period; not a drug addict, but still not an "ordinary non-addict". The patients sleep and work/ study in a particular setting, both symbolically and practically separated from their previous (drug) milieu and the rest of society (Nøkleby & Skårderud, 2013) . In (Kanayama et al., 2009; Rohman, 2009; Trenton & Currier, 2005) .
Limitations
This study has used a non-validated ver- 
